We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advises on Assessing Gastric pH-Dependent Drug-Drug Interactions
FDA Advises on Assessing Gastric pH-Dependent Drug-Drug Interactions
The FDA outlined its current thinking for drug sponsors on assessing gastric pH-dependent drug-drug interactions (DDI) in a final guidance released Monday.